IL-2 induces the stimulation of inflammatory and immune reactions, and the apoptosis of antigenactivated cells. However, the molecular basis of these pleiotropic functions is largely unknown. We have previously reported that IL-2 induces genes involved in cytoskeleton organization, oncogene regulation and transcriptional control. In an IL-2-dependent cell line, we have also shown that IL-2 induces tumor necrosis factor (TNF)-β mRNA through the Jak-STAT pathway. Here, we first demonstrate in vitro that IL-2 induces mature and partially spliced TNF-β mRNA in the splenocytes and lymph node cells of both IL-2 -/-and IL-2 ⍣/-mice. Under the same experimental conditions, IL-2 is seen to induce TNF-α mRNA. mRNA expression is followed by semiquantitative RT-PCR and this analysis is then extended in vivo by studying different lymphoid organs from IL-2 -/-animals. Strikingly, the expression of TNF-β mRNA is noted to be extremely low in the spleens and lymph nodes of IL-2 -/-mice. Similarly, TNF-α, lymphotoxin (LT)-β, TNFR1 and TNFR2 mRNA levels are also low in the spleens of IL-2 -/-animals, whereas IFN-γ and IL-4 mRNA levels remain unaffected in these animals. The experimental values are significantly different (P ≤ 0.05) from those of control IL-2 ⍣/-animals. Western blot analysis of TNF-α expression confirmed and extended the results at the protein level. For the first time, we demonstrate that IL-2 directly or indirectly regulates genes of the TNF-TNFR family in secondary lymphoid organs. Furthermore, IL-2 -/-animals in which thymopoiesis is unaffected show normal expression of these genes. Altogether, our data further define the pleiotropic effects of IL-2 at the molecular level.
Introduction
IL-2 is a pleiotropic cytokine predominantly produced by involving a cell line grown in IL-2 or IL-4. Of these genes, those coding for cytoskeleton proteins (α-tubulin, β catenin), CD4 ϩ T lymphocytes (1). It exerts its effects on various cell types such as T, B, NK cells and monocytes by binding to oncogene-regulating proteins [CTCF, Jun inhibition factor (JIF)-1] and transcriptional factors (E2F4, CREB, ZhX-1) were its receptors (2-4). IL-2 has numerous functions including survival, activation, growth and differentiation of immune cells.
further studied in vivo using IL-2 -/-animals (6). These genes are underexpressed in the spleens and lymph nodes of ILIn addition, IL-2 has also been implicated in programmed cell death (5). To understand the molecular basis of the 2 -/-mice, suggesting that they may play a role in determining the phenotype of IL-2 -/-animals by influencing gene exprespleiotropic functions of IL-2, we previously characterized IL-2-inducible genes using a cDNA subtraction approach sion, oncogene regulation and cellular adhesion. As an example, abnormal lymphocyte activation and proliferation in Methods IL-2 -/-mice is followed by lymphocyte hyperplasia characterMice ized by splenomegaly, lymphadenopathy and colitis
The IL-2 -/-and IL-2 ϩ/-mice have already been described depending on age, genetic background and breeding condi-(7). They were bred in the animal facilities of the Pasteur tions (7-10). While it has been suggested that the above Institute and were genotyped by PCR (7). The mice were phenotype may occur due to a defect in the FAS-mediated housed under conventional conditions and animals~3 months death pathway (10,11) or a lack of CD4 ϩ CD25 ϩ T cells (12), old were used for the study. we proposed that faulty expression of multiple IL-2-inducible genes leads to the complex phenotype found in IL-2 -/-mice Preparation of cells and flow cytometric analysis (6). Hence it is essential to verify in vivo the role played by Splenocytes were prepared from whole spleens after treat-IL-2 in the induction of genes characterized as IL-2-inducible ment with ammonium chloride to remove erythrocytes. Lymph in vitro (13).
node and thymus cells were used as single-cell suspensions. Recently, we used a suppression-subtraction hybridization Lymphocyte subsets were characterized by suspending approach to demonstrate that IL-2 also induces tumor 5ϫ10 5 cells in 0.1 ml PBS (0.5% FCS and 0.02% sodium necrosis factor (TNF)-β in an IL-2-dependent CTLL-2 cell azide) then staining with FITC-labeled mAb for 30 min on ice line via the Jak-STAT signal transduction pathway (14) . TNF and washing before analysis. When indicated the activation and TNFR belong to a large family of molecules of which of the different cell subsets was measured by adding phyco-TNF-α, TNF-β [also designated as lymphotoxin (LT)-α], erythrin (PE)-conjugated anti-CD69 mAb during the incubation LT-β, TNFR1 and TNFR2 have been extensively studied period. Flow cytometry was performed with a FACScan flow (15). As well as regulating cell proliferation and apoptosis cytometer (Becton Dickinson, Mountain View, CA). (16, 17) , the TNF-TNFR system also plays an important
The following mAb were prepared in the Pasteur Institute, role in the control of lymphoid organogenesis (18, 19) .
Department of Immunology: FITC-conjugated anti-CD3 mAb Furthermore, TNF-α and TNF-β induce MHC class I and (clone 2 C113.4), FITC-conjugated anti-CD4 mAb (clone class II antigens (20, 21) as well as chemokines, and play GK1.5), FITC-conjugated anti-CD8 mAb [clone (α)53.6.72], a critical role in cell-cell interactions and lymphocyte FITC-conjugated anti-B220 mAb (clone Ra3B2), FITC-conjugtrafficking (22, 23) . TNFs are also known to be involved in ated anti-NK1.1 mAb (clone PK136) and FITC-conjugated the defense against pathogens and in the induction of anti-Mac-1 mAb (clone M1/70). PE-labeled anti-CD69 mAb inflammatory and autoimmune diseases (15,24). TNF-β (clone H1.2F3) was obtained from PharMingen-Clinisciences enhances cytotoxic responses against normal and trans-(Montrouge, France). formed cell types (25) (26) (27) . TNF would therefore appear to be essential in the regulation and maintenance of immune Cell culture system homeostasis under normal and pathological conSingle-cell suspensions were prepared from spleens and ditions.
from a pool of mesenteric, inguinal and popliteal lymph nodes The effect of IL-2 on TNF-β induction in the CTLL-2 cell line taken from IL-2 -/-and IL-2 ϩ/-mice. Briefly, the tissues were suggests that IL-2 may have a critical impact on the expression homogenized in HBSS containing 10 mM HEPES and 10% of the TNF family of molecules and therefore may be an FCS. The cells were washed twice and then cultured in important link in the cytokine network. This hypothesis was complete medium at a density of 1ϫ10 6 cells/ml in 75 cm 2 tested at different levels. The positive effect of IL-2 on TNF-β flasks. The complete medium consisted of RPMI 1640 mRNA expression was first confirmed in vitro using polyclonal medium, 5% FCS, 2 mM glutamine, 10 mM HEPES, 2 µM 2-lymphocytes from the lymph nodes and spleens of IL-2 -/-and mercaptoethanol, penicillin (1000 U/ml), streptomycin (1 mg/ IL-2 ϩ/-mice. Our analysis was then extended in vivo to ml) and fungizone (250 ng/ml) with or without IL-2 (5 nM). TNF-β mRNA expression in the lymph nodes, spleens and An aliquot was taken from both the IL-2-stimulated and thymuses of IL-2 -/-animals. IL-2 ϩ/-animals were used as unstimulated spleen cell cultures after 0, 0.5, 6, 12 and 24 h, controls during this analysis. The expression of TNF-β mRNA and after 0, 0.5 and 6 h from the lymph node cells. RNA was found to be substantially reduced in the lymph nodes extraction was followed by measurement of mRNA expression and spleens of IL-2 -/-mice. By contrast, TNF-β was expressed for TNF-β, TNF-α, LT-β, TNFR1 and TNFR2. normally in the thymus of IL-2 -/-mice. The expression of TNF-RNA extraction, DNase I treatment and cDNA synthesis α was studied at the mRNA and protein levels. The expression of LT-β, TNFR1 and TNFR2 mRNA was also analyzed both Total RNA was extracted from the spleens, lymph nodes and in vitro and in vivo. The results suggest that IL-2 also plays thymuses of both IL-2 -/-and IL-2 ϩ/-mice using RNA PLUS an important role in the in vivo regulation of these molecules. reagent (Quantum Bioprobe, Montreuil, France). RNA (1 µg) Altogether, the data obtained indicate that TNF-β and molecfrom each sample was exposed to amplification grade DNase ules of the TNF and TNFR family follow the same pattern of I (Gibco/BRL, Cergy Pontoise, France). The first-strand cDNA expression we previously described for IL-2Rα, β-catenin, was synthesized from the DNase-treated RNA using oligo CTCF, JIF-1, E2F4, CREB, ZhX1 and nucleolin (6), and are (dT) 12-18 (25 ng/µl) by incubating the mixture at 70°C for highly susceptible to the effects of IL-2 in the secondary 10 min followed by quick chilling on ice. The following were lymphoid organs, but not in the thymus. This provides an then added according to the manufacturer's instructions: additional insight into the mechanisms explaining the pleio5ϫfirst-strand buffer, 0.1 M DTT, dNTP mix, Superscript II reverse transcriptase (Gibco/BRL) and RNAsin (2 U/µl) tropic effects of IL-2. The PCR products were transferred onto Hybond-Nϩ mem-PCR branes (Amersham Life Science) and hybridized with genespecific probes (Table 1 ). The hybridization temperatures cDNA mixture (2 µl) was used for PCR amplifications using gene-specific primers (Table 1) . Since the primers used for used were 58°C (TNF-β and IL-4), 52°C (TNF-α and LT-β), 50°C (IFN-γ), 56°C (TNFR1 and TNFR2) and 68°C (β-actin). TNF-β, TNF-α, LT-β, IFN-γ and IL-4 spanned the introns, the cDNA-derived PCR products could be distinguished from For TNF-β, TNF-α, LT-β, IL-4, IFN-γ, TNFR1 and TNFR2, the membranes were hybridized overnight using 20 pM of each of the genomic DNA-amplified fragments by their size. All the reactions were carried out at a primer concentration of 0.12 µM the corresponding [ 32 P]dATP-radiolabeled oligonucleotides.
[ 32 P]dCTP-labeled cDNA fragments were used for the detecin 25 µl containing 25 mM TAPS-HCl (pH 9.3), 50 mM KCl, 2 mM MgCl 2 , 1 mM 2-mercaptoethanol, 10 mM each of tion of β-actin. The membranes were washed twice with 5ϫSSC and 0.1% SDS for all the genes except β-actin for dATP, dTTP, dGTP and dCTP, and 1.25 U cloned Taq DNA polymerase (Amersham Life Science, Cleveland, OH). The which 2ϫSSC and 0.1% SDS were used. The hybridized membranes were then exposed to Kodak storage phosreactions were performed using a Thermal Cycler (Perkin Elmer Applied Biosystems) as previously described (6).
phorus screens. The radioactive signals corresponding to cytokine mRNA After initial denaturation (94°C/3 min) the cycling for each gene was conducted as follows (indicated in the order of (e.g. TNF-β) and β-actin mRNA were measured using a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). A denaturation, annealing and extension): TNF-β: 94°C/30 s, 53°C/30 s, 72°C/1 min; TNF-α: 94°C/1.5 min, 62°C/2 min and semiquantitative analysis of cytokine mRNA expression was obtained by dividing the radioactive signals for cytokine 72°C/2 min (28); LT-β: 95°C/1 min, 52°C/1 min and 72°C/2 min (29); TNFR1: 94°C/1.5 min, 55°C/2 min and 72°C/2 min mRNA by the radioactive signals for β-actin mRNA and reporting the result as a ratio, i.e. TNF-β/β-actin (6,33). The (30); TNFR2: 94°C/1 min, 62°C/1 min and 72°C/2 min (31); IFN-γ and IL-4: 94°C/1 min, 60°C/1 min and 72°C/2 min (32); effect of IL-2 in in vitro studies was then determined as the ratio between IL-2-stimulated and unstimulated ratios for a and β-actin: 94°C/30 s, 59°C/20 s and 72°C/20 s. In addition, a final 7 min extension at 72°C was included at the end of 25 given cytokine, e.g. IL-2 effect for TNF-β ϭ TNF-β/β-actin ratio in IL-2-stimulated cells/TNF-β/β-actin ratio in unstimulated cycles for all the genes. The PCR products were resolved on 2.0% agarose gel electrophoresis, stained with ethidium cells. Filters were blocked for 2 h at room temperature with blocking radiographed for a few seconds.
Western blot analysis
TNF-α protein expression levels was quantified by densitometry. β-Actin on the same blots was measured using mAb (clone C-2, IgG1; Santa Cruz Biotechnology, Le Perray, be explained by the difference in the genetic background of France). Bands corresponding to the amount of TNF-α or β-the animals used in the two studies. In the same manner as for actin were measured using NIH Image software (National the lymph nodes, the distribution of the different lymphocyte Institutes of Health, Bethesda, MD). The TNF-α signal was subsets in the spleens of IL-2 -/-and IL-2 ϩ/-animals did not first normalized to that of β-actin and the TNF-α/β-actin ratio show any significant difference (data not shown). As far as calculated. The IL-2 effect was calculated by dividing the the thymus is concerned, we confirmed our previous results TNF-α/β-actin ratio obtained from IL-2 -/-and IL-2 ϩ/-mice by indicating that all the major thymocyte subpopulations are the TNF-α/β-actin ratio of IL-2 -/-mice. expressed in IL-2 -/-mice (13). The activation status of the different lymphocyte subsets Statistics found in the lymph nodes taken from IL-2 -/-and IL-2 ϩ/-mice In vitro experiments were performed to study the IL-2-induced was also analyzed. Table 2 shows the results obtained by expression of TNF-TNFR mRNA in spleen and lymph node measuring the expression of the early activation marker cells cultured in the absence or the presence of IL-2. A CD69. All subsets from the lymph nodes of IL-2 -/-mice were representative experiment is shown for each analysis. Groups activated. A low but significant proportion of lymphocytes of five to nine mice were chosen for the in vivo studies. The from IL-2 ϩ/-mice were also expressing CD69. Comparable ratios between TNF-β, TNF-α, LT-β, IFN-γ, IL-4, TNFR1 and results were obtained in spleen samples from IL-2 -/-animals TNFR2 mRNA expression and β-actin mRNA expression were (data not known). Altogether, our data confirm over-activation analyzed statistically as described previously (6). Student's of the different lymphocyte subsets in the absence of IL-2. t-test was used to determine the significance of the results Under these conditions, the activated lymphocytes should (P Ͻ 0.05 was considered significant). The mean Ϯ SD of produce more cytokines unless IL-2 is required for their the ratios is shown for each group of animals.
production.
In vitro expression of TNF-β, TNF-α and LT-β mRNA by Results splenocytes from IL-2 -/-and IL-2 ϩ/-mice stimulated with IL-2 Expression of lymphocyte subsets in IL-2-deficient mice
IL-2 induced the expression of TNF-β mRNA in splenocytes from both IL-2 -/-and IL-2 ϩ/-mice (Fig. 1) . Expression of TNFDisruption of the IL-2 gene has no major effect on either thymocyte production or peripheral mature T cell seeding (7). Before β showed two mRNA species (485 and 709 bp) corresponding to mature and a partially spliced (PS) mRNA respectively comparing the expression of molecules in the TNF-TNFR family by IL-2 -/-and IL-2 ϩ/-mice we verified the distribution of the (Fig. 1A) . The PS mRNA, containing intron 3, was distinguished from possible genomic DNA-amplified products by RNase various lymphocyte subsets among the lymph nodes, spleens and thymuses of these two mouse strains. Table 2 shows the and DNase treatments. The existence of PS TNF-β mRNA exported into the cytoplasm as a mature message is unique results obtained for the lymph nodes, with five animals being analyzed. Percentages of CD3, CD4 and CD8 lymphocytes (35) . The biological role of this transcript is unknown. When stimulating splenocytes in vitro, IL-2 up-regulated TNF-β were comparable between the IL-2 -/-and IL-2 ϩ/-animals. Contrary to previously published results (34) we did not detect any mRNA expression in both IL-2 -/-and IL-2 ϩ/-mice as early as 30 min post-stimulation ( Fig. 1A and B) . Both mature and difference in the percentage of B220 ϩ lymphocytes expressed by the IL-2 -/-and IL-2 ϩ/-mouse strains. This discrepancy might PS TNF-β mRNA followed the same time course response, peaking at 6 h post-stimulation (Fig. 1B) . Of the two transcripts, β mRNA calculated as described in Methods increased gradually, and peaked at 24 h in both IL-2 -/-and IL-2 ϩ/-mature mRNA levels remained consistently higher than those of PS TNF-β mRNA. The effect of IL-2 on mature and PS TNFsplenocytes (Fig. 1B) .
The expression of TNF-α and LT-β mRNA was analyzed PS TNF-β mRNA were always lower than the levels of mature TNF-β mRNA. The expression of PS TNF-β mRNA was found under similar experimental conditions (Fig. 1B) . Time-course responses showed that TNF-α mRNA was up-regulated by to be reduced in the spleens and lymph nodes of IL-2 -/-mice. However, the underexpression of PS TNF-β mRNA in IL-2 to peak 6 h after IL-2 stimulation in both IL-2 -/-and IL-2 ϩ/-splenocytes. The effect of IL-2 on TNF-α mRNA expression IL-2 -/-mice was less significant than for mature TNF-β mRNA. It may therefore be concluded that the in vivo expression of reached a maximum at 24 h (Fig. 1B) . When considering LT-β mRNA, the response of splenocytes from IL-2 -/-mice PS TNF-β mRNA is less affected by IL-2 than that of mature TNF-β mRNA. followed a similar pattern in the absence and the presence of IL-2. The response of splenocytes from IL-2 ϩ/-animals Expression of TNF-α, LT-β, IFN-γ and IL-4 mRNA in spleens was decreased in unstimulated and IL-2-stimulated cultures from IL-2 -/-and IL-2 ϩ/-mice (Fig. 1B) . This suggests that IL-2 does not significantly effect the expression of LT-β mRNA and that the overexpression mRNA expression for TNF-α, LT-β, IL-4 and IFN-γ was studied in vivo in the spleens of IL-2 -/-and IL-2 ϩ/-mice (Fig. 4) . TNFnoted in IL-2 ϩ/-splenocytes was not found in vitro, even in the presence of IL-2.
α and LT-β belong to the TNF family and were included as a comparison with TNF-β expression. TNF-α mRNA was In vitro expression of TNF-β, TNF-α and LT-β mRNA by lymph diminished in spleens, while LT-β mRNA expression was very node cells from IL-2 -/-and IL-2 ϩ/-mice stimulated with IL-2 low in IL-2 -/-(P ϭ 0.077 and P ϭ 0.027 respectively) compared to IL-2 ϩ/-animals. IFN-γ and IL-4, the classical markers of The expression of TNF-β, TNF-α and LT-β mRNA was studied 0, 0.5 and 6 h post-stimulation in lymph node cells from T h 1 and T h 2 differentiation, were included as cytokine controls (36) . We anticipated that IFN-γ mRNA expression would be IL-2 -/-and IL-2 ϩ/-mice cultured in the absence and the presence of IL-2. Since the induction of TNF-β and TNF-α underexpressed in IL-2 -/-mice since this cytokine has been reported to be induced by IL-2 in a murine lymphocyte cell mRNA peaked after 6 h in the splenocytes, we chose this same time point for our studies in cultured lymph node cells.
line (CTLL) (37) . By contrast, IL-4 levels were expected to be increased since overproduction of IgG1 and IgE isotypes has IL-2 up-regulated TNF-β mRNA expression in IL-2-stimulated lymph node cells. Marked induction of TNF-β was noted been observed in IL-2 -/-mice (7). However, IFN-γ mRNA expression was not significantly altered in IL-2 knockout after 6 h, particularly in cells from IL-2 -/-animals ( Fig. 2A and  B) . Since IL-2 also induced TNF-β in lymph node cultures animals (Fig. 4) . Likewise, the expression of IL-4 mRNA did not differ significantly between IL-2 -/-and IL-2 ϩ/-animals. from IL-2 ϩ/-animals, a positive IL-2 effect was therefore observed in IL-2-stimulated cultures from both strains. As Hence, IFN-γ and IL-4 could be used as in vivo controls for IL-2-modulated genes such as TNF-β, TNF-α and LT-β. already seen in splenocytes, mature TNF-β mRNA levels in lymph node cells were always more elevated than PS TNF-β Thymuses from IL-2 -/-and IL-2 ϩ/-mice were also studied for TNF-α, LT-β and IL-4 mRNA expression. No significant mRNA. When considering TNF-α, its mRNA expression was found to be up-regulated by IL-2 after 6 h of stimulation and differences were found between the two strains, suggesting that the thymic expression of genes of the TNF family, such the effect of IL-2 was more pronounced in IL-2-stimulated IL-2 ϩ/-than in IL-2 -/-lymph node cells (Fig. 2B) . As already as TNF-β, TNF-α and LT-β, is not affected by IL-2 (data not shown). seen in splenocytes, LT-β mRNA levels did not show a response pattern suggestive of IL-2 induction (Fig. 2B) .
In vitro and in vivo expression of TNFR1 and TNFR2 mRNA In vivo expression of TNF-β mRNA in the spleens, lymph
Both TNF-β and TNF-α homotrimers use TNFR1 and TNFR2 nodes and thymuses of IL-2 -/-and IL-2 ϩ/-mice (15,38,39). To test whether IL-2 has any impact on TNFR expression, mRNA for TNFR1 and TNFR2 was evaluated in Our in vitro experiments showed that polyclonal lymphocytes from the spleens or lymph nodes of IL-2 -/-or IL-2 ϩ/-mice spleen and lymph node cells from either IL-2 -/-or IL-2 ϩ/-animals, cultured in the absence or the presence of IL-2 (Fig. maintained a comparable capacity to induce TNF-β mRNA synthesis after IL-2 stimulation. Our analysis was then 5). IL-2 did not have an obvious effect on TNFR1 and TNFR2 mRNA expression in splenocytes since their expression was extended to TNF-β mRNA expression in vivo by studying spleens, lymph nodes and thymuses from both IL-2 -/-and also increased in unstimulated cultures (Fig. 5A ). The IL-2 effect measured during time-course experiments did not show IL-2 ϩ/-mice. TNF-β mRNA expression both in vivo and in vitro revealed mature and PS TNF-β mRNA (Fig. 3A) . As shown in any consistent increase, thus suggesting that TNFR1 and TNFR2 expression in vitro is unaffected by IL-2 (Fig. 5A ). This Fig. 3(B) , mature TNF-β mRNA levels were far lower in the spleens of IL-2 -/-than in the spleens of IL-2 ϩ/-mice was confirmed by studying lymph node cell cultures. Timecourse responses to IL-2 were followed and the IL-2 effect (P ϭ 0.00003). Mature TNF-β mRNA was also expressed to a lesser extent in lymph nodes from IL-2 -/-mice when calculated. The results obtained showed that IL-2 had little effect on TNFR1 and TNFR2 mRNA expression in these compared to IL-2 ϩ/-mice (P ϭ 0.038). By contrast, the thymus did not show any difference in the expression of mature cultures, regardless of the genetic origin of the cells (IL-2 -/-or IL-2 ϩ/-) (Fig. 5B) . TNF-β mRNA between the two genotypes (Fig. 3B) .
PS TNF-β mRNA was also studied in the spleens, lymph Since IL-2 had little effect on TNFR expression in IL-2-stimulated spleen or lymph node cell cultures, we anticipated nodes and thymuses of IL-2 -/-and IL-2 ϩ/-mice ( Fig. 3A and  B) . Its expression may have been affected by the in vivo that its expression would remain unaltered in different lymphoid organs from IL-2 -/-mice. Hence, we verified the activation of lymphocytes from IL-2 -/-mice. However, regardless of the organ or genotype studied, expression levels of expression of TNFR1 and TNFR2 in lymph nodes, spleens The time-course response for TNF-β, TNF-α and LT-β mRNA in both IL-2-stimulated and unstimulated cells was semiquantitatively analyzed by normalizing to β-actin mRNA. TNF-β/β actin, TNF-α/β actin and LT-β/β actin ratios are reported. The IL-2 effect was then determined as a ratio between IL-2-stimulated and unstimulated ratios.
and thymuses from IL-2 -/-mice. The results were compared with TNF-β, TNF-α and LT-β, the thymic expression of TNFR1 and TNFR2 mRNA was comparable in IL-2 -/-and IL-2 ϩ/-with those obtained using IL-2 ϩ/-mice. Contrary to our expectations, TNFR1 and TNFR2 mRNA expression was animals (Fig. 6) . Therefore, it may be concluded that IL-2 has an effect on the in vivo expression of TNFR, but that the significantly reduced in spleens from IL-2 -/-as compared with IL-2 ϩ/-mice (P ϭ 0.0004 and P ϭ 0.016 respectively) pattern of regulation is complex since it mainly affects the expression of these two receptors in the spleen. (Fig. 6) . However, and in agreement with the results obtained Fig. 3 . In vivo expression of TNF-β mRNA in the spleens, lymph nodes and thymuses of IL-2 -/-and IL-2 ϩ/-mice. (A) Total RNA was extracted from the spleens, lymph nodes and thymuses of IL-2 -/-and IL-2 ϩ/-mice. The expression of TNF-β mRNA (mature mRNA, 485 bp; PS mRNA, 709 bp) was examined by RT-PCR. Amplified products were transferred onto Hybond-Nϩ membranes and hybridized with a TNF-β-specific probe. The radioactive signals were recorded for TNF-β and β-actin mRNA in spleens from IL-2 -/-and IL-2 ϩ/-mice using a PhosphorImager. (B) mRNA expression for TNF-β was semiquantitatively analyzed in spleens, lymph nodes and thymuses by normalizing to β-actin mRNA. TNF-β/β-actin ratios are reported. Mean Ϯ SD and P values are indicated.
Expression of TNF-α in spleens, lymph nodes and thymuses
conditions it was noted that TNF-α is clearly less expressed in the spleen and lymph nodes of IL-2 -/-animals than in the taken from IL-2 -/-and IL-2 ϩ/-mice same organs of IL-2 ϩ/-animals (Fig. 7B) . Thymuses from both IL-2 modulation of mRNA from molecules of the TNF-TNFR genotypes expressed similar amounts of TNF-α. These results family was studied by semi-quantitative PCR. To obtain more therefore extend to a protein level the results previously seen extensive results at the protein level we analyzed TNF-α by semi-quantitative PCR. expression using the Western blot technique since a reliable and well-characterized mAb against murine TNF-α was available (40) . By contrast, the specificity and reliability of other Discussion immunological reagents against TNF-β, LT-β and TNFR remain questionable.
To progressively unravel the pleiotropic functions of IL-2, we began by conducting a study of IL-2-induced genes Figure 7 shows the results obtained with hamster antimurine TNF-α mAb (clone TN3-19.12). It has recently been characterized using cDNA subtraction or suppressionsubtraction hybridization approaches (6,14). In the present recognized that this reagent reacts with both the immature (26 kDa) precursor and the mature (17 kDa) form of TNF-α paper, we extend our previous studies concerning the regulation of IL-2-induced genes coding for proteins involved in (40) . Studies on cell extracts from spleen, lymph node and thymus showed that mAb TN3-19.12 recognized only the cytoskeleton organization, oncogene regulation and transcriptional control to the TNF-TNFR family. Our recent observation immature form of TNF-α (Fig. 7A) . Under these experimental concerning IL-2-regulation of TNF-β expression was made using an IL-2-dependent cell line. Here, these results were first confirmed in vitro after culturing polyclonal lymphocytes in the presence or the absence of IL-2. Furthermore, and more importantly, we reported for the first time that TNF-β mRNA is regulated by IL-2 in vivo. Similarly, we observed that Fig. 4 . Expression of TNF-α, LT-β, IFN-γ and IL-4 mRNA in the spleens of IL-2 -/-and IL-2 ϩ/-mice. Total RNA was extracted from the spleens of IL-2 -/-and IL-2 ϩ/-mice. mRNA expression for TNF-α, LT-β, IFN-γ, IL-4 and β-actin was measured by semiquantitative RT-PCR. Amplified products were transferred onto Hybond-Nϩ membranes and hybridized with TNF-α, LT-β, IFN-γ, IL-4 and β-actin-specific probes. The radioactive signals were recorded using a PhosphorImager. mRNA expression was analyzed by normalizing to β-actin mRNA. TNF-α/β-actin, LT-β/β-actin, IFN-γ/β-actin and IL-4/β-actin ratios are reported. Mean Ϯ SD and P values are indicated.
Fig. 5.
In vitro effect of IL-2 on the expression of TNFR1 and TNFR2 mRNA in spleen and lymph node cells from IL-2 -/-and IL-2 ϩ/-mice. (A) Splenocytes from IL-2 -/-and IL-2 ϩ/-mice were cultured with or without IL-2. The time-course response for TNFR1 and TNFR2 was examined after 0, 0.5, 6, 12 and 24 h by RT-PCR. Amplified products were transferred onto Hybond-Nϩ membranes, and hybridized with TNFR1, TNFR2 and β-actin-specific probes. The radioactive signals were recorded using a PhosphorImager. mRNA expression was semiquantitatively analyzed by normalizing to β-actin mRNA. TNFR1/ β-actin and TNFR2/β-actin ratios are reported. The effect of IL-2 was then determined as a ratio between IL-2-stimulated and unstimulated ratios. (B) Lymph node cells from IL-2 -/-and IL-2 ϩ/-mice were cultured with or without IL-2. TNFR1 and TNFR2 mRNA expression was followed over 6 h. The effect of IL-2 on TNFR1 and TNFR2 expression was determined as in (A) and as discussed in Methods. Fig. 7 . Expression of TNF-α in the spleens, lymph nodes and thymuses of IL-2 -/-and IL-2 ϩ/-mice. Protein lysates were prepared from the spleens, lymph nodes and thymuses of IL-2 -/-and IL-2 ϩ/-mice (three animals for each genotype). TNF-α protein and β-actin expression were sequentially examined by Western blot. After electrophoretic migration the products were transferred to membranes and revealed by the corresponding mAb followed by staining with the specific peroxidase-labeled polyclonal antibodies. The signals obtained (ECL) Fig. 6 . Expression of TNFR1 and TNFR2 mRNA in the spleens, lymph were quantified using NIH Image software. The TNF-α signal was nodes and thymuses of IL-2 -/-and IL-2 ϩ/-mice. Total RNA was normalized to the β-actin signal and the IL-2 effect was calculated extracted from the spleens, lymph nodes and thymuses of IL-2 -/-as described in Methods. and IL-2 ϩ/-mice, and mRNA expression for TNFR1, TNFR2 and β-actin was examined by semiquantitative RT-PCR. Amplified products were transferred onto Hybond-Nϩ membranes and hybridized with TNFR1-, TNFR2-and β-actin-specific probes. The radioactive signals were recorded using a PhosphorImager. mRNA expression for TNFR1 results support our previous observation that IL-2 induced and TNFR2 was analyzed by normalizing to β-actin signal. TNFR1/β-TNF-β in an IL-2-responsive cell line (14). Under the same actin and TNFR2/β-actin ratios are reported. Mean Ϯ SD and P values are indicated.
experimental conditions, IL-2 also up-regulated TNF-α, although to a lesser extent (Figs 1 and 2 ). This result is comparable to that obtained after stimulating murine T cell lines by anti-CD3 or IL-2 (37, 41) . By contrast, IL-2 has no effect on LT-β expression in vitro. Similarly, the effect of IL-2 TNF-α, LT-β, TNFR1 and TNFR2 mRNA are underexpressed in IL-2 -/-animals. Western blot analysis of TNF-α expression on TNFR1 and TNFR2 expression in vitro was slight and probably not significant (Fig. 5) . It has already been reported confirmed and extended these results at the protein level.
IL-2 induces TNF-β mRNA in splenocytes and lymph node that IL-2 induces TNFR expression in normal human lymphocytes after 5-9 days of culture (42) . Therefore, independent cells from IL-2 -/-and IL-2 ϩ/-animals (Figs 1 and 2) . These of species differences, long-term culturing may be required TNF-β was extremely low in spleens from IL-2 -/-mice, we anticipated that both TNF-β -/-and IL-2 -/-phenotypes would for IL-2-enhanced expression of TNFR in vitro.
The expression of TNF-β in spleens, lymph nodes and show common pathological features. IL-2 -/-mice develop splenomegaly and polyadenomegaly due to the accumulation thymuses of IL-2 -/-mice was analyzed to test the hypothesis that TNF-β could be underexpressed in vivo. As shown in of blast-like T cells in spleen white pulp and in the paracortex of hypertrophied lymph nodes. The structure of these two Fig. 3 , both mature and PS TNF-β mRNA were present at extremely low levels in spleens from IL-2 -/-mice compared secondary lymphoid organs is nevertheless maintained (8,9,45,46). By contrast, no such lesions have been encounto IL-2 ϩ/-mice (P ϭ 0.00003). This was also the case in lymph nodes, but with a narrower difference (P ϭ 0.038). It tered in TNF-β -/-mice nor in mice deficient for receptors interacting with TNF-β or TNF-α (18, 19, 47, 48) . TNF-β -/-mice is worthy of note that our data obtained by analyzing lymphoid organs of naive animals in the absence of any known stimulalack lymph nodes and Peyer's patches, and their spleens show a loss of B and T cell zone compartmentalization, tion. As reported in Table 2 , lymphocytes from IL-2 -/-animals were overactivated compared to cells of IL-2 ϩ/-mice. Despite reduced white pulp with no B cell follicles and no germinal centers (18, 19, 49, 50) . Since no apparent correlation could this strong activation, lymphocytes from IL-2 -/-mice produced less TNF-β mRNA than cells from IL-2 ϩ/-mice. This underlines be found between IL-2 -/-and TNF-β -/-pathological features, this implies that low amounts of TNF-β may be sufficient for the specific role of IL-2 in the modulation of the TNF-β gene. Interestingly, the underexpression was noted solely in the lymphoid organogenesis of secondary lymphoid organs in IL-2 -/-mice. Alternatively, TNF-β-related molecules may peripheral lymphoid organs, i.e. spleen and lymph nodes, but not in thymus (Fig. 3) . We previously reported that ILcompensate for the decreased expression of TNF-β in IL-2 -/-mice. However, we did notice that IL-2 -/-mice show 2Rα, β-catenin, CTCF, JIF-1 and nucleolin mRNA, while expressed normally in thymus, were found to be underperivascular mononuclear cell infiltration in several nonlymphoid organs (colon, rectum, liver, esophagus, kidney, expressed in the secondary lymphoid organs of IL-2 -/-mice (6,13). This indicates that IL-2-inducible genes, including pancreas, salivary glands and lungs) (personal observations) (8,9,45,46,51). Such a feature has also been reported in TNF-β, may not have any major impact on thymus differentiation which otherwise is normal in IL-2 -/-mice. These results TNF-β -/-(19) and LT-β-R -/-mice (52) . Therefore, it may be speculated that the underexpression of TNF-β in IL-2 -/-could also suggest that IL-2-inducible genes in thymus may be regulated by other molecules. The possible involvement of play a role in the perivascular infiltration observed in this model. IL-15 has already been excluded (13). It is worthy of note that lymphocyte hyperplasia occurs in peripheral lymphoid IL-2 -/-mice develop lymphocyte hyperplasia resulting from uncontrolled proliferation of lymphocytes in secondary organs but not in the thymus of IL-2 -/-mice. The underexpression of IL-2-induced genes and peripheral lymphocyte proliflymphoid organs (8-10). Three possible mechanisms have been put forward to explain this phenomenon. (i) At the eration are therefore correlated, and this further supports the hypothesis that the families of genes we have characterized molecular level, it has been shown that IL-2 suppresses FLICE inhibitory protein (FLIP), the negative regulator of FAS and contribute toward the phenotype of IL-2 -/-mice.
Although TNF-α and LT-β belong to the same family as TNF-mediated death pathways. The absence of IL-2 results in increased levels of FLIP (11,53). In addition, lymphocytes TNF-β (15), the regulation of their expression is different. Comparisons of in vitro and in vivo findings suggest that ILfrom IL-2 -/-mice show increased resistance to FAS-mediated cell death (10). Hence it is suggested that the cell accumula-2 induces TNF-α mRNA and we have previously demonstrated that IL-2-induced expression of TNF-β mRNA involves the tion may be the consequence of FLIP overexpression followed by a defect in FAS-mediated apoptosis.
(ii) At the cellular Jak-STAT pathway of IL-2R signaling (14). It therefore remains to be determined whether this pathway in also involved in level, a lack of CD4 ϩ CD25 ϩ T cells has been implicated in the occurrence of colitis in IL-2 -/-mice (12). CD4 ϩ CD25 ϩ T TNF-α expression. In our studies, LT-β mRNA was not induced in vitro, yet its expression was diminished in spleens from cells have been proposed as 'professional suppressor cells' and can suppress polyclonal T cell activation by inhibiting IL-IL-2 -/-mice (Fig. 4) . This indicates that LT-β expression is affected by IL-2 in vivo but that the corresponding regulation 2 production. They can also act by antigen-presenting cellindependent mechanisms in an antigen non-specific manner pathway is not functioning in vitro. Similarly, the effect of IL-2 on TNFR was marginal in vitro and their expression was low (54,55). They are believed to exert their suppressive function via the production of IL-10 (12). Their absence in IL-2 -/-mice in spleens from IL-2 -/-mice, thus indicating that IL-2 may also control TNFR expression in vivo (Fig. 6) . The fact that might also explain the uncontrolled lymphocyte activation. (iii) From our data, we suggest that the IL-2 -/-phenotype is under TNF-β, TNF-α and LT-β expression is diminished in vivo may contribute indirectly to the reduced expression of TNFR multigenic control. We have previously identified new IL-2-inducible genes coding for cytoskeleton proteins (α-tubulin, (43,44). We show as controls that the expression of IFN-γ and IL-4 did not differ significantly between IL-2 -/-and IL-2 ϩ/-mice β catenin), oncogene-regulating proteins (CTCF, JIF-1), transcriptional factors (E2F4, CREB, ZhX-1) and IL-2Rα (6,13). α (Fig. 4) , implying that their expression is IL-2 independent. Furthermore, our results indicate that the lymphocyte activaand β catenin provide a link between T cell surface-expressed cadherins and actin cytoskeleton filaments (6,56,57). The fact tion found in IL-2 -/-mice, as measured by activation markers such as CD69 and CD71 (13), does not systematically lead that these genes are underexpressed in IL-2 -/-mice may lead to faulty adhesion and the release of lymphocytes from to cytokine overproduction.
It has been reported that TNF-β-deficient mice show defects normal regulatory control by cell-cell contact. In addition, the underexpression of CTCF and JIF-1, which suppress c-myc in lymphoid organogenesis (18, 19 ). Since we observed that STAT signal transducers and activators of transcription and c-jun respectively, may provide an explanation for the TNF tumor necrosis factor lymphocyte proliferation observed in IL-2 -/-animals. The low levels of transcriptional factors (E2F4, CREB, ZhX-1) may also induce faulty expression of genes critical to the control of References lymphocyte physiology. Hence, we propose that regulatory dysfunction of multiple IL-2-inducible genes is responsible
